134 related articles for article (PubMed ID: 35976038)
1. The Effect of Metabolic Syndrome on Colorectal Cancer Prognosis after Primary Surgery.
Tao W; Yuan C; Kang B; Liu XY; Cheng YX; Zhang B; Wei ZQ; Peng D
Nutr Cancer; 2023; 75(1):331-338. PubMed ID: 35976038
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract][Full Text] [Related]
3. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
4. The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females.
Chen ZF; Dong XL; Huang QK; Hong WD; Wu WZ; Wu JS; Pan S
World J Surg Oncol; 2018 Aug; 16(1):163. PubMed ID: 30097069
[TBL] [Abstract][Full Text] [Related]
5. The association of Metabolic Syndrome and its Components with the Incidence and Survival of Colorectal Cancer: A Systematic Review and Meta-analysis.
Han F; Wu G; Zhang S; Zhang J; Zhao Y; Xu J
Int J Biol Sci; 2021; 17(2):487-497. PubMed ID: 33613107
[No Abstract] [Full Text] [Related]
6. Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis.
Chen XL; Chen ZQ; Zhu SL; Liu TW; Wen Y; Su YS; Xi XJ; Hu Y; Lian L; Liu FB
BMC Cancer; 2017 Apr; 17(1):240. PubMed ID: 28376764
[TBL] [Abstract][Full Text] [Related]
7. The effect of metabolic syndrome on postoperative complications and long-term survival of patients with colorectal cancer.
Zhu C; Mao C; Cai W; Zheng J; Yang H; You T; Chen J; Yu Y; Shen X; Li L
Front Oncol; 2023; 13():1036458. PubMed ID: 37434983
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between metabolic syndrome and prognosis of patients with clear cell renal cell carcinoma].
Zuo MN; DU YQ; Yu LP; Dai X; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):636-643. PubMed ID: 35950385
[TBL] [Abstract][Full Text] [Related]
10. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
Choi YJ; Lee DH; Han KD; Shin CM; Kim N
Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
[TBL] [Abstract][Full Text] [Related]
11. Does chronic kidney disease affect the complications and prognosis of patients after primary colorectal cancer surgery?
Liu XY; Zhang B; Cheng YX; Tao W; Yuan C; Wei ZQ; Peng D
World J Gastrointest Oncol; 2022 Jun; 14(6):1199-1209. PubMed ID: 35949210
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.
You J; Liu WY; Zhu GQ; Wang OC; Ma RM; Huang GQ; Shi KQ; Guo GL; Braddock M; Zheng MH
Oncotarget; 2015 Aug; 6(23):19880-90. PubMed ID: 26082438
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer.
Ko EJ; Kim EJ; Cho HJ; Oh J; Park HS; Ryu CS; Kim JO; Jun HH; Chong SY; Kim JW; Kim NK
Genes Genomics; 2022 Jun; 44(6):659-670. PubMed ID: 35377131
[TBL] [Abstract][Full Text] [Related]
14. The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis.
Yang Z; Zhang M; Peng R; Liu J; Wang F; Li Y; Zhao Q; Liu J
Int J Colorectal Dis; 2020 Sep; 35(9):1651-1661. PubMed ID: 32666290
[TBL] [Abstract][Full Text] [Related]
15. Does Preoperative Waiting Time Affect the Short-Term Outcomes and Prognosis of Colorectal Cancer Patients? A Retrospective Study from the West of China.
Liu XY; Li ZW; Kang B; Cheng YX; Tao W; Zhang B; Zhang H; Wei ZQ; Peng D
Can J Gastroenterol Hepatol; 2022; 2022():8235736. PubMed ID: 35535032
[TBL] [Abstract][Full Text] [Related]
16. Interaction of smoking and metabolic syndrome in increasing the recurrence risk of colorectal cancer in a Chinese male cohort: a retrospective study.
Chen DZ; Ji FY; Xu QM; Wu XX; Cai C; Zhang LJ; Li LJ
Sci Rep; 2018 Jan; 8(1):972. PubMed ID: 29343809
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis.
Huang CY; Zhou QY; Hu Y; Wen Y; Qiu ZW; Liang MG; Mo JL; Xu JH; Sun C; Liu FB; Chen XL
Oncotarget; 2017 Apr; 8(14):23459-23469. PubMed ID: 28423584
[TBL] [Abstract][Full Text] [Related]
18. Higher body mass index was associated with better prognosis in diabetic patients with stage II colorectal cancer.
Liu XY; Kang B; Cheng YX; Yuan C; Tao W; Zhang B; Wei ZQ; Peng D
BMC Cancer; 2022 Jun; 22(1):596. PubMed ID: 35641911
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study.
Feng Q; Tang LJ; Luo DH; Wang Y; Wu N; Chen H; Chen MX; Jiang L; Jin R
Cancer Manag Res; 2021; 13():8809-8819. PubMed ID: 34866939
[TBL] [Abstract][Full Text] [Related]
20. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis.
Wang B; Li F; Zhou X; Ma Y; Fu W
World J Surg Oncol; 2019 Oct; 17(1):169. PubMed ID: 31639018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
